---
title: FDA Panel Recommends Moderna Booster for Vulnerable Individuals
description: An independent panel of vaccine experts recommended the Moderna booster shots to those who are at high risk of contracting COVID-19.
---

[Employee Benefit News for School, City and County Employers ](https://blog.nisbenefits.com)

# [FDA Panel Recommends Moderna Booster for Vulnerable Individuals](https://blog.nisbenefits.com/fda-panel-recommends-moderna-booster)

 Written by [Erin Woulfe](https://blog.nisbenefits.com/author/erin-woulfe) | Oct 27, 2021 11:36:19 AM

*1.5 minute read*

Recently, an independent panel of vaccine experts recommended the Moderna booster shots to those who are at high risk of contracting COVID-19. This includes people over the age of 65, younger adults with health issues, and those with occupational exposure to COVID-19.

This nonbinding panel advises the Food and Drug Administration (FDA) and encouraged half-dose Moderna vaccine shots for those who previously received that vaccine. The FDA usually follows the panel’s endorsement guidance, recently making the same recommendation regarding the Pfizer-BioNTech vaccine.

The latest recommendation is for the vulnerable populations only. There is no current evidence to suggest that most Americans need a booster shot at this time. The FDA has only reviewed Pfizer and Moderna booster shots. The panel is expected to review Johnson & Johnson soon.

Individuals should continue to monitor the FDA for updates. [Download the bulletin](https://blog.nisbenefits.com/hubfs/Blog%20-%20supporting%20documents/bulletin-fda-moderna-booster-vulnerable.pdf) for more details.

*This blog is intended to be a compilation of information and resources pulled from federal, state, and local agencies. This is not intended to be legal advice. For up to the minute information and guidance on COVID-19, please follow the guidelines of the Centers for Disease Control and Prevention (CDC) and your local health organizations.*

[View full post](https://blog.nisbenefits.com/fda-panel-recommends-moderna-booster)

```json
{
  "@context" : "http://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Erin Woulfe"
  },
  "dateModified" : "2021-10-27T11:36:19.393Z",
  "datePublished" : "2021-10-27T11:36:19Z",
  "headline" : "FDA Panel Recommends Moderna Booster for Vulnerable Individuals",
  "image" : {
    "@type" : "ImageObject",
    "height" : 500,
    "url" : "https://info.nisbenefits.com/hubfs/blog-headers/fda-moderna-booster-b.jpg",
    "width" : 800
  },
  "mainEntityOfPage" : "https://blog.nisbenefits.com/fda-panel-recommends-moderna-booster",
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "height" : 60.0,
      "url" : "https://info.nisbenefits.com/hubfs/NIS_March_2025/Images/NIS%20Logo%20Footer.png",
      "width" : 218.18182
    },
    "name" : "Employee Benefit News for School, City and County Employers"
  }
}
```